Shanghai Shen Lian Biomedical Corporation (SHA:688098)
China · Delayed Price · Currency is CNY 8.37
+0.05 (0.60%)
Aug 4, 2026, 3:00 PM CST
SHA:688098 Market Cap
SHA:688098 has a market cap or net worth of 3.39 billion as of August 4, 2026. Its market cap has decreased by -1.96% in one year.
Market Cap
3.39B
Enterprise Value
3.33B
Revenue
272.12M
Ranking
n/a
PE Ratio
n/a
Stock Price
8.37
ChartMarket Cap Chart
Since October 28, 2019, SHA:688098's market cap has decreased from 15.08B to 3.39B, a decrease of -77.53%. That is a compound annual growth rate of -19.79%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 4, 2026 | 3.39B | -7.09% |
| Dec 31, 2025 | 3.65B | 62.34% |
| Dec 31, 2024 | 2.25B | -26.87% |
| Dec 29, 2023 | 3.07B | -5.79% |
| Dec 30, 2022 | 3.26B | -28.08% |
| Dec 31, 2021 | 4.53B | -31.23% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 28, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Sihuan Bioengineering | 3.72B |
| Beijing Scitop Bio-tech | 3.67B |
| Pulike Biological Engineering | 3.55B |
| Assure Tech (Hangzhou) | 3.55B |
| Boji Medical Technology | 3.51B |
| Kexing Biopharm | 3.50B |
| Shanghai Obio Technology (Group) Corp. | 3.48B |
| Lifecome Biochemistry | 3.34B |